Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease
Pathology · 2023
DOI: 10.1016/j.pathol.2023.08.006 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pathology, 2023. Verfasst von Elizabeth M Forbes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Queensland, Brisbane, Qld, Australia. Electronic address: Elizabeth.Forbes@health.qld.gov.au. Hauptthemen laut MEDLINE: Glutamate Decarboxylase, Nervous System Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pathology Queensland, Brisbane, Qld, Australia. Electronic address: Elizabeth.Forbes@health.qld.gov.au.
- Pathology Queensland, Brisbane, Qld, Australia.
- Pathology Queensland, Brisbane, Qld, Australia; Princess Alexandra Hospital, Brisbane, Qld, Australia.
- Pathology Queensland, Brisbane, Qld, Australia; Sunshine Coast University Hospital, Birtinya, Qld, Australia.
Zitieren
APA
Forbes, E. M., Prain, K. M., Wong, R. C., & Gillis, D. (2023). Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease. Pathology. https://doi.org/10.1016/j.pathol.2023.08.006
Vancouver
Forbes EM, Prain KM, Wong RC, Gillis D. Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease. Pathology. 2023. doi:10.1016/j.pathol.2023.08.006
BibTeX
@article{Forbes2023,
author = {Forbes, Elizabeth M and Prain, Kerri M and Wong, Richard C and Gillis, David},
title = {Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease},
journal = {Pathology},
year = {2023},
doi = {10.1016/j.pathol.2023.08.006}
}
EUVIMED